- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine and phencyclidine: the good, the bad and the unexpected
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 17, Pages 4254-4276
Publisher
Wiley
Online
2015-06-15
DOI
10.1111/bph.13222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-NMDA receptor encephalitis, autoimmunity, and psychosis
- (2016) Matthew S. Kayser et al. SCHIZOPHRENIA RESEARCH
- Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial
- (2015) Peter Nagele et al. BIOLOGICAL PSYCHIATRY
- First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine
- (2015) S. P. Elliott et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Schizophrenia drug discovery and development in an evolving era: Are new drug targets fulfilling expectations?
- (2015) John Dunlop et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anesthetic Neurotoxicity — Clinical Implications of Animal Models
- (2015) Bob A. Rappaport et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice
- (2015) Shunsuke Takagi et al. SCHIZOPHRENIA RESEARCH
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Phencyclidine Inhibits the Activity of Thalamic Reticular Gamma-Aminobutyric Acidergic Neurons in Rat Brain
- (2014) Eva Troyano-Rodriguez et al. BIOLOGICAL PSYCHIATRY
- From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs
- (2014) Hamilton Morris et al. Drug Testing and Analysis
- Developing treatments for cognitive deficits in schizophrenia: The challenge of translation
- (2014) JW Young et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dissecting negative symptoms in schizophrenia: Opportunities for translation into new treatments
- (2014) George Foussias et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Recent genetic findings in schizophrenia and their therapeutic relevance
- (2014) Paul J Harrison JOURNAL OF PSYCHOPHARMACOLOGY
- NMDA Antagonists for Refractory Seizures
- (2014) F. A. Zeiler et al. Neurocritical Care
- Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive Following Acute Ketamine in Rats
- (2014) Rosalyn J Moran et al. NEUROPSYCHOPHARMACOLOGY
- Magnesium in depression
- (2014) Anna Serefko et al. Pharmacological Reports
- Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
- (2014) Eline M.P. Poels et al. SCHIZOPHRENIA RESEARCH
- Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder
- (2014) Daniel M. Pearlman et al. SCHIZOPHRENIA RESEARCH
- GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
- (2014) Oliver H Miller et al. eLife
- Modulation of Adult Hippocampal Neurogenesis by Early-Life Environmental Challenges Triggering Immune Activation
- (2014) Ksenia Musaelyan et al. NEURAL PLASTICITY
- Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring
- (2014) T Uchida et al. Translational Psychiatry
- New paradigms for treatment-resistant depression
- (2013) Carlos Zarate et al. Annals of the New York Academy of Sciences
- Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis
- (2013) Julia Deakin et al. BIOLOGICAL PSYCHIATRY
- Do Neuronal Autoantibodies Cause Psychosis? A Neuroimmunological Perspective
- (2013) Ester Coutinho et al. BIOLOGICAL PSYCHIATRY
- Regulation of N-Methyl-D-Aspartate Receptors by Disrupted-in-Schizophrenia-1
- (2013) Jing Wei et al. BIOLOGICAL PSYCHIATRY
- Ketamine for chronic pain: risks and benefits
- (2013) Marieke Niesters et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Advantages of an antagonist: bicuculline and other GABA antagonists
- (2013) Graham AR Johnston BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ketamine in Pain Management
- (2013) Jan Persson CNS Neuroscience & Therapeutics
- Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia
- (2013) David A Lewis CURRENT OPINION IN NEUROBIOLOGY
- Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study
- (2013) Nicolas Gaspard et al. EPILEPSIA
- Reviewing the ketamine model for schizophrenia
- (2013) Joel Frohlich et al. JOURNAL OF PSYCHOPHARMACOLOGY
- GluN2B Antagonism Affects Interneurons and Leads to Immediate and Persistent Changes in Synaptic Plasticity, Oscillations and Behavior
- (2013) Jesse E Hanson et al. NEUROPSYCHOPHARMACOLOGY
- Chronic ketamine produces altered distribution of parvalbumin-positive cells in the hippocampus of adult rats
- (2013) Jonathan J. Sabbagh et al. NEUROSCIENCE LETTERS
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor
- (2013) Bryan L. Roth et al. PLoS One
- Nonhuman primate model of schizophrenia using a noninvasive EEG method
- (2013) R. Gil-da-Costa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain
- (2013) Juan M. Lima-Ojeda et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
- (2013) Melissa A. Snyder et al. Frontiers in Cellular Neuroscience
- Rethinking schizophrenia in the context of normal neurodevelopment
- (2013) Vibeke S. Catts et al. Frontiers in Cellular Neuroscience
- Involvement of the N-methyl-d-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity
- (2013) Hideko Yamamoto et al. Molecular Brain
- Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
- (2013) Nina V. Kraguljac et al. JAMA Psychiatry
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
- (2012) Ruin Moaddel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
- (2012) C S Weickert et al. MOLECULAR PSYCHIATRY
- Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
- (2012) Judith Pratt et al. NATURE REVIEWS DRUG DISCOVERY
- NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
- (2012) John A. Saunders et al. NEUROBIOLOGY OF DISEASE
- Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators
- (2012) Daniel T. Monaghan et al. NEUROCHEMISTRY INTERNATIONAL
- The NMDA receptor as a target for cognitive enhancement
- (2012) Graham L. Collingridge et al. NEUROPHARMACOLOGY
- Prenatal NMDA Receptor Antagonism Impaired Proliferation of Neuronal Progenitor, Leading to Fewer Glutamatergic Neurons in the Prefrontal Cortex
- (2012) Kazuya Toriumi et al. NEUROPSYCHOPHARMACOLOGY
- CNTRICS final animal model task selection: Control of attention
- (2012) C. Lustig et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet?
- (2012) D. C. Javitt SCHIZOPHRENIA BULLETIN
- Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future
- (2012) E. F. Domino et al. SCHIZOPHRENIA BULLETIN
- Capturing the Angel in "Angel Dust": Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
- (2012) B. Moghaddam et al. SCHIZOPHRENIA BULLETIN
- NMDA Receptor and Schizophrenia: A Brief History
- (2012) J. T. Coyle SCHIZOPHRENIA BULLETIN
- Epigenetics of major psychosis: progress, problems and perspectives
- (2012) Viviane Labrie et al. TRENDS IN GENETICS
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- Differential Role of NR2A and NR2B Subunits in N-Methyl-D-Aspartate Receptor Antagonist-Induced Aberrant Cortical Gamma Oscillations
- (2011) Bernat Kocsis BIOLOGICAL PSYCHIATRY
- mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
- (2011) Jason M. Dwyer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted-In-Schizophrenia 1 (DISC1)
- (2011) Takashi Namba et al. JOURNAL OF NEUROCHEMISTRY
- Genetic mouse models relevant to schizophrenia: Taking stock and looking forward
- (2011) Paul J. Harrison et al. NEUROPHARMACOLOGY
- Contributions of the d-serine pathway to schizophrenia
- (2011) Viviane Labrie et al. NEUROPHARMACOLOGY
- GABAergic interneuron origin of schizophrenia pathophysiology
- (2011) Kazu Nakazawa et al. NEUROPHARMACOLOGY
- Signaling pathways underlying the rapid antidepressant actions of ketamine
- (2011) Ronald S. Duman et al. NEUROPHARMACOLOGY
- Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
- (2011) Susan B. Powell et al. NEUROPHARMACOLOGY
- NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis
- (2011) Gary Gilmour et al. NEUROPHARMACOLOGY
- Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia
- (2011) J.M. McNally et al. NEUROSCIENCE
- Subanaesthetic Ketamine Treatment Alters Prefrontal Cortex Connectivity With Thalamus and Ascending Subcortical Systems
- (2011) Neil Dawson et al. SCHIZOPHRENIA BULLETIN
- Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
- (2011) Anouk Marsman et al. SCHIZOPHRENIA BULLETIN
- Preclinical Evidence Toward the Use of Ketamine for Recombinant Tissue-Type Plasminogen Activator-Mediated Thrombolysis Under Anesthesia or Sedation
- (2011) Clement Gakuba et al. STROKE
- A Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury
- (2010) Robert W. Teasell et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABAA receptor binding
- (2010) Richard J. Beninger et al. BEHAVIOURAL PHARMACOLOGY
- Disruption of Performance in the Five-Choice Serial Reaction Time Task Induced By Administration of N-Methyl-D-Aspartate Receptor Antagonists: Relevance to Cognitive Dysfunction in Schizophrenia
- (2010) Nurith Amitai et al. BIOLOGICAL PSYCHIATRY
- Mouse behavioral endophenotypes for schizophrenia
- (2010) Laura C. Amann et al. BRAIN RESEARCH BULLETIN
- Long-term depression in the CNS
- (2010) Graham L. Collingridge et al. NATURE REVIEWS NEUROSCIENCE
- Abnormal neural oscillations and synchrony in schizophrenia
- (2010) Peter J. Uhlhaas et al. NATURE REVIEWS NEUROSCIENCE
- Gamma Oscillatory Power is Impaired During Cognitive Control Independent of Medication Status in First-Episode Schizophrenia
- (2010) Michael J Minzenberg et al. NEUROPSYCHOPHARMACOLOGY
- Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
- (2010) Joanna C. Neill et al. PHARMACOLOGY & THERAPEUTICS
- Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine
- (2010) Yoko Hagino et al. PLoS One
- A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists
- (2009) Jerry J. Buccafusco et al. BIOCHEMICAL PHARMACOLOGY
- Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade
- (2009) Teresa Marie du Bois et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Neuroprotection by Ketamine: A Review of the Experimental and Clinical Evidence
- (2009) Judith A. Hudetz et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
- HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
- (2009) X. Chen et al. JOURNAL OF NEUROSCIENCE
- Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
- (2009) S. E. Kotermanski et al. JOURNAL OF NEUROSCIENCE
- HCN1 channels constrain DHPG-induced LTD at hippocampal Schaffer collateral-CA1 synapses
- (2009) T. Tokay et al. LEARNING & MEMORY
- Urine Drug Screening: Practical Guide for Clinicians
- (2009) Karen E. Moeller et al. MAYO CLINIC PROCEEDINGS
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- (2009) Juan E Belforte et al. NATURE NEUROSCIENCE
- Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-d-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors
- (2009) Kate E. Gilling et al. NEUROPHARMACOLOGY
- Differential role of N-methyl-d-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits
- (2009) N.C. Anastasio et al. NEUROSCIENCE
- Dopamine D2Highreceptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil
- (2009) Philip Seeman et al. SYNAPSE
- Evaluation of a neurodevelopmental model of schizophrenia—Early postnatal PCP treatment in attentional set-shifting
- (2008) Brian Villumsen Broberg et al. BEHAVIOURAL BRAIN RESEARCH
- The destruction of the lower urinary tract by ketamine abuse: a new syndrome?
- (2008) Peggy Sau-Kwan Chu et al. BJU INTERNATIONAL
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- N-methyl-d-aspartic acid receptor antagonist–induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia
- (2008) R.S. Ehrlichman et al. NEUROSCIENCE
- Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats
- (2008) Alice Egerton et al. PSYCHOPHARMACOLOGY
- Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat—a back translational study
- (2008) Pascal Goetghebeur et al. PSYCHOPHARMACOLOGY
- Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
- (2008) Karsten Heekeren et al. PSYCHOPHARMACOLOGY
- Region-Specific Changes in Gamma and Beta2 Rhythms in NMDA Receptor Dysfunction Models of Schizophrenia
- (2008) A. K. Roopun et al. SCHIZOPHRENIA BULLETIN
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now